Clinical Study to Evaluate the Effect of Food Supplement in People Infected With Coronavirus

PHASE2CompletedINTERVENTIONAL

Enrollment

224

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

September 1, 2021

Study Completion Date

February 3, 2022

Conditions

COVID-19 Virus Infection

Interventions

DIETARY_SUPPLEMENT

LCLT : 68% elemental L-carnitine and 32 % Tartric acid

3 g orally capsules

DRUG

Placebo

orally capsules

Trial Locations (1)

Senai Cimatec, Salvador

All Listed Sponsors

collaborator

Hospital Espanhol

NETWORK

lead

SENAI CIMATEC

OTHER

NCT05446961 - Clinical Study to Evaluate the Effect of Food Supplement in People Infected With Coronavirus | Biotech Hunter | Biotech Hunter